Therapeutic closure of the ductus arteriosus: Benefits and limitations

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 22, Issue SUPPL. 3, 2009, Pages 14-20

  Mercanti, Isabelle ^a   Boubred, Farid ^a   Simeoni, Umberto ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Ibuprofen; Indomethacin; Patent ductus arteriosus; Premature infant

Indexed keywords

DOPAMINE; FUROSEMIDE; IBUPROFEN; INDOMETACIN; MEFENAMIC ACID; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; SURFACTANT;

ADVERSE OUTCOME; ARTERY LIGATION; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CLIP; COMORBIDITY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DIURESIS; DRUG EFFECT; DRUG EFFICACY; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY; ELECTROLYTE DISTURBANCE; FETUS DEATH; GLOMERULUS FILTRATION RATE; HEART LEFT RIGHT SHUNT; HUMAN; IMMATURITY; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY PERFUSION; LOW DRUG DOSE; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROLENTAL FIBROPLASIA; REVIEW; RISK BENEFIT ANALYSIS; THORACOTOMY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR PATENCY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DUCTUS ARTERIOSUS, PATENT; EVIDENCE-BASED MEDICINE; GESTATIONAL AGE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES;

EID: 70449433076     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050903198132     Document Type: Review

References (61)

1. Clyman R. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006;89:330-335.
2. Herrmes-De Santis E, Clyman R. Patent ductus arteriosus: pathophysiology and management. J Perinatol 2006;26:S14-S18.
3. Krauss A, Fatica N, Lewis B, Cooper R, Thaler H, Cirrincione C, O'Loughlin J, Levin A, Engle MA, Auld PA. Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child 1989;143:78-81.
4. Farstad T, Bratlid D. Pulmonary effects of closure of patent ductus arteriosus in premature infants with severe respiratory distress syndrome. Eur J Pediatr 1994;153:903-905.
5. Stefano J, Abbasi S, Pearlman S, Spear M, Esterly K, Bhutani V. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation. Am Rev Respir Dis 1991;143:236-239.
6. Yeh T, Thalji A, Luken L, Lilien L, Carr I, Pildes R. Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus. Chest 1981;80:698-700. (Pubitemid 12247517)
7. Morrow R, Taylor A, Kinsella J, Lally K, Gerstmann D, DeLemos R. Effects of ductal patency on organ blood flow and pulmonary function in the preterm baboon with hyaline membrane disease. Crit Care Med 1995;23:179-186.
8. Gerhardt T, Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate 1980;38:96-105.
9. Naulty C, Horn S, Conry J, Avery J. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr 1978;93:682-684.
10. Rojas M, Gonzalez A, Bancalari E, Claure N, Poole C, Silva- Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995;126:605-610.
11. Marshall D, Kotelchick M, Young T, Bose C, Kruyer L, O'Shea T. Risk factors for chronic lung disease in the surfactant era: a north Carolina population-based study of very low birth weight infants. Pediatrics 1999;104:1345-1350.
12. Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 2005;88:192-201.
13. Laughon M, Ma S, Bose C. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr 2004;16:146-151.
14. Dollburg S, Lusky A, Reichman B. Patent ductus arteriosus, indomethacin and necrotising enterocolitis in very low birth weight infants: a population based-study. J Pediatr Gastroenterol Nutr 2005;40:184-188.
15. Van De Bor M, Verloove-Vanhorick S, Brand R, Ruys J. Patent ductus arteriosus in a cohort of 1338 preterm infants: a collaborative study. Paediatr Perinat Epidemiol 1988;2:328-336.
16. Bomelburg T, Jorch G. Abnormal blood flow patterns in renal arteries of small preterm infants with patent ductus arteriosus detected by Doppler ultrasonography. Eur J Pediatr 1989;148:660-664.
17. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183-F186. (Pubitemid 126439147)
18. Pladys P, Beuchee A, Wodey E, Treguier C, Lassel L, Betremieux P. Patent ductus arteriosus and cystic periventricular leucomalacia in preterm infants. Acta Paediatr 2001;90:309-315.
19. Gonzalez A, Sosenko I, Chandar J, Hummler H, Claure N, Bancalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-478.
20. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld C. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-1121.
21. Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 2006;72:179-184.
22. Heldt G, Pesonen E, Merritt T, Elias W, Sahn D. Closure of the ductus arteriosus and mechanics of breathing in preterm infants after surfactant replacement therapy. Pediatr Res 1989;25:305-310.
23. Reller M, Buffkin D, Colasurdo M, Rice M, McDonald R. Ductal patency in neonates with respiratory distress syndrome. A randomized surfactant trial. Am J Dis Child 1991;145:1017-1020.
24. Kluckow M, Evans N. Early echographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 1995;127:774-779.
25. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:F419-F422.
26. Kwinta P, Rudzinski A, Kruczek P, Kordon Z. Can early echographic findings predict patent ductus arteriosus? Neonatology 2009;95:141-148.
27. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002;161:202-207.
28. Itabashi K, Ohno T, Nishida H. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomathacin. J Pediatr 2003; 143:203-207.
29. Brooks J, Travadi J, Patole S, Doherty D, Simmer K. Is surgical ligation of patent ductus arteriosus necessary? The western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed 2005;90:F235-F239.
30. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards A. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42.
31. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-738.
32. Grosfeld J, Chaet M, Molinari F, EngleW, Engum S, West K, Rescorla FJ, Scherer LR 3rd. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996;224:350-357.
33. Guthrie S, Gordon P, Thomas V, Thorp J, Peabody J, Clark R. Necrotizing enterocolitis among neonates in the United States. J Perinatol 2003;23:278-285.
34. Van Overmeire B, Van De Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 2001;138:205-211.
35. Thomas R, Parker G, Van Overmeire B, Aranda J. A metaanalysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-140.
36. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2008;1:CD003481.
37. Van Overmeire B, Follens I, Hartmann S, Creten W, Van Acker K. Treatment of patent ductus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997;76:F179-F184.
38. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997;131:549-554.
39. Naulaers G, Delanghe G, Allegaert K, Debeer A, Cossey V, Vanhole C, Casaer P, Devlieger H, Van Overmeire B. Ibuprofen and cerebral oxygenation and circulation. Arch Dis Child Fetal Neonatal Ed 2005;90:F75-F76.
40. Gournay V, Savagner C, Thiriez G, Kuster A, Roze J. Pulmonary hypertension after ibuprefen prophylaxis in very preterm infants. Lancet 2002;359:1486-1488.
41. Mosalli R, AlFaleh K. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev 2008;1:CD006181.
42. Niinikoski H, Alanen M, Parvinen T, Aantaa R, Ekblad H, Kero P. Surgical closure of patent ductus arteriosus in verylow- birth-weight infants. Pediatr Surg Int 2001;17:338-341.
43. Gersony W, Peckham G, Ellison R, Miettinen O, Nadas A. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
44. Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg 2006;81:231-235.
45. Vida VL, Lago P, Salvatori S, Bocuzzo G, Padalino M, Milanesi O, Speggiorin S, Stellin G. Is there an optimal timing for surgical ligation of patent ductus arteriosus in preterm infants? Ann Thorac Surg 2009;87:1509-1516.
46. Mikhail M, Lee W, Toews W, Synhorst D, Hawes C, Hernandez J, Lockhart C, Whitfield J, Pappas G. Surgical and medical experience with 734 premature infants with patent ductus arteriosus. J Thorac Cardiovasc Surg 1982;83:349-357.
47. Vanderhaegen J, De Smet D,Meyns B, Van De Velde M, Van Huffel S, Naulaers G. Surgical closure of the patent ductus arteriosus and its effect on cerebral tissue oxygenation. Acta Paediatr 2008;97:1640-1644.
48. Kabra N, Schmidt B, Roberts R, Doyle L, Papile L, Fanaroff A. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results of the trial of indomethacin prophylaxis in preterms. J Pediatr 2007;150:229-234.
49. Madan J, Kendrick D, Hagadorn J, Frantz I. Patent ductus arteriosus: impact on neonatal and 18-month outcome. Pediatrics 2009;123:674-681.
50. Chorne N, Leonard C, Piecuch R, Clyman R. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity.Pediatrics 2007;119:1165-1174.
51. Knight D. The treatment of patent ductus arteriosus in preterm infants. A review and overview of randomized trials. Semin Neonatol 2001;6:63-73.
52. Schmidt B, Roberts R, Fanaroff A, Davis P, Kirpalani H, Nwaesei C, Vincer M; TIPP Investigators. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the trial of indomethacin prophylaxis in preterms (TIPP). J Pediatr 2006;148:730-734.
53. Fowlie P, Davis P. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002;(3):CD000174.
54. Gournay V, Roze J, Kuster A, Daoud P, Cambonie G, Hascoet J, Chamboux C, Blanc T, Fichtner C, Savagner C, et al. prophylactic ibuprofen versus placebo in very prematurei nfants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1939-1944.
55. Van Overmeire B, Allegaert K, Casaer P, Debauche C, Decaluwe W, Jespers A, Weyler J, Harrewijn I, Langhendries JP. Prophylactic ibuprofen in premature infats: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2004;364:1945-1949.
56. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, Rubaltelli FF. Prophylactic ibuprofen for the prevention of intraventricular haemorrhage among preterm infants: a multicenter, randomized study. Pediatrics 2005;115:1529-1535.
57. Ohlsson A, Shah S. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;1:CD004213.
58. Vanhaesebrouck S, Zonnenberg I, Van Dervoort P, Bruneel E, Van Hoestenberghe M, Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007;92:F244-F247.
59. Herrman K, Bose C, Lewis K, Laughon M. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed 2009;94:F48-F50.
60. Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Saugstad OD, Simeoni U, Speer CP, Soler A, Valls I, et al. European consensus panel on neonatal respiratory distress syndrome. J Perinat Med 2007;35:175-186.
61. Giniger RP, Buffat C, Millet V, Simeoni U. Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infants. J Matern Fetal Neonatal Med 2007;20:275-283.